ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Interpretable PROTAC Degradation Prediction With Structure-Informed Deep Ternary Attention Framework.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Artificial intelligence empowers targeted protein degradation: Core technological innovations, multi-scenario applications, and translational prospects.Smart molecules : open access · 2026Review
- Pocket-PROTACs: an interpretable pocket-aware deep learning framework for predicting PROTAC-induced protein degradation.Bioinformatics (Oxford, England) · 2026Article
- SE(3)-PROTACs: Geometric deep learning for PROTAC degradation prediction.Briefings in bioinformatics · 2026Article
- From undruggable to degradable: A deep learning-enabled framework for precision orthopaedic protein degradation.Journal of orthopaedic translation · 2026Review
- PROTAC-Splitter: a machine learning framework for automated identification of PROTAC substructures.Journal of cheminformatics · 2026Article
- Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibition.Journal of nanobiotechnology · 2026Article
- Opening the black box: insights into ubiquitin-mediated control of innate antiviral immunity and AI-enhanced therapeutics.Frontiers in immunology · 2026Review
- Interpretable PROTAC Degradation Prediction With Structure-Informed Deep Ternary Attention Framework.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Accurate PROTAC-targeted degradation prediction with DegradeMaster.Bioinformatics (Oxford, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Proteolysis Targeting Chimeras (PROTACs) are heterobifunctional ligands bridging Proteins-Of-Interest (POIs) and E3 ligases for ubiquitin-proteasome degradation, promising to target the 'undruggable'. While PROTAC research primarily relies on costly and time-consuming wet-lab experiments, deep learning offers potential to accelerate development and reduce expenses. However, many deep learning methods for PROTAC degradation prediction overlook hierarchical molecular representation and protein structural data, hindering data modeling. Moreover, their black-box nature hampers interpretability, failing to provide intuitive insights into substructure interactions within the PROTAC system. This study introduces PROTAC-STAN, a structure-informed deep ternary attention network (STAN) framework for interpretable PROTAC degradation prediction. PROTAC-STAN represents PROTAC molecules across atom, molecule, and property hierarchies and incorporates structure information for POIs and E3 ligases via protein language model. Furthermore, it simulates interactions among three entities at substructure levels via a novel ternary attention network tailored for the PROTAC system, providing unprecedented insights into the degradation mechanism. PROTAC-STAN yields over 10% improvement across multiple metrics compared to the best baselines, while providing significant interpretability through atomic and residue level visualization of molecule and complex. Exploratory evaluations and case studies demonstrate strong real-world applicability. The excellence of PROTAC-STAN is anticipated to establish a foundational tool for future PROTAC research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.